Brought to you by 
CR Bard gets world rights to Trimedyne's Lateralase
13 Jul 1999
Executive Summary
CR Bard gets exclusive worldwide marketing rights to Trimedyne's Lateralase catheter for urologic, gynecologic and gastroenterologic applications under a newly signed agreement between the companies.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CR Bard gets world rights to Trimedyne's Lateralase
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice